Booster Dose of COVID-19 Vaccine for Kidney Transplant Recipients Without Adequate Humoral Response

Clinical trial NCT04961229 · UNKNOWN

Trial details

NCT number: NCT04961229
Sponsor: dafna yahav
Status: UNKNOWN
Phase: Phase 4
Study type: INTERVENTIONAL

COVID-19 Acute Respiratory Distress Syndrome Immunosuppression

Start date: 2021-10-01
Primary completion: 2022-02-01
Enrollment: 504

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.